Tag: Gore Excluder
US FDA approves labelling update reflecting evidence in ruptured AAA for...
Gore today announced that the US Food and Drug Administration (FDA) has approved updated labelling for the Gore Excluder abdominal aortic aneurysm (AAA) endoprosthesis...
Gore reports first clinical use of TAMBE device in Japan
Gore in Japan has announced the first clinical use of the Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) in the East Asian country. The device,...
One-year TAMBE data highlight low mortality, importance of renal branch assessment
The four-branch Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) device demonstrated low mortality at one year with renal artery occlusion being the predominant device-related event...
Gore announces first commercial implant of Excluder conformable AAA endoprosthesis with...
Gore recently announced the first commercial use of its Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis with Active Control system in Canada.
The news coincides...
One-year results confirm safety and efficacy of conformable AAA device in...
Results of a sub-study from the pivotal investigational device exemption (IDE) trial assessing Gore’s Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis have shown...
